NoWonder Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 15

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $24M

  • Investors
  • 10

NoWonder General Information

Description

Developer of a nitric oxide-releasing technology designed to treat upper respiratory and dermal infections. The company's technology provides first-line non-antibiotic antimicrobials for use against bacteria, viruses, and fungi, enabling medical industry professionals to treat a broad spectrum of infectious pathogens and topical infections.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 8180 South 700 East
  • Suite 350
  • Sandy, UT 84070
  • United States
+1 (888)
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Vertical(s)
Corporate Office
  • 8180 South 700 East
  • Suite 350
  • Sandy, UT 84070
  • United States
+1 (888)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NoWonder Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series B) 24-Aug-2022 $24M Completed Generating Revenue
7. Early Stage VC 01-Dec-2021 Completed Clinical Trials - Phase 3
6. Early Stage VC (Series A) 01-Aug-2021 Completed Clinical Trials - Phase 2
5. Grant 31-Dec-2020 Completed Clinical Trials - Phase 2
4. Equity Crowdfunding Completed Clinical Trials - Phase 2
3. Grant 05-Jun-2020 Completed Clinical Trials - Phase 2
2. Seed Round 29-Feb-2020 $2.45M $2.65M Completed Clinical Trials - Phase 1
1. Angel (individual) 01-May-2018 $200K $200K Completed Clinical Trials - Phase 1
To view NoWonder’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

NoWonder Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a nitric oxide-releasing technology designed to treat upper respiratory and dermal infections. The company'
Drug Delivery
Sandy, UT
15 As of 2022

Vienna, Austria
 

Parsippany, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NoWonder Competitors (47)

One of NoWonder’s 47 competitors is Pfizer (Vienna), a Corporation company based in Vienna, Austria.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pfizer (Vienna) Corporation Vienna, Austria
Melinta Therapeutics Private Equity-Backed Parsippany, NJ
Pfizer Pakistan Corporation Karachi, Pakistan
Lakewood-Amedex Formerly VC-backed University Park, FL
Scynexis Formerly VC-backed Jersey City, NJ
You’re viewing 5 of 47 competitors. Get the full list »

NoWonder Patents

NoWonder Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025238414-A1 Foot bath trays and systems Pending 15-May-2024
US-D1084873-S1 Nasal spray bottle Active 01-Oct-2021
US-D1133149-S1 Nasal spray bottle Active 01-Oct-2021
AU-2021344727-A1 Dual-chamber spray device Pending 16-Sep-2020
CA-3192725-A1 Dual-chamber spray device Pending 16-Sep-2020 A61M11/007
To view NoWonder’s complete patent history, request access »

NoWonder Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NoWonder Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
ABC International (Vancouver) Corporation Minority
Horizons Ventures Venture Capital Minority
The Global Value Investment Portfolio Management Venture Capital Minority
Happiness Capital Corporate Venture Capital Minority
Impact Assets Impact Investing Minority
You’re viewing 5 of 10 investors. Get the full list »

NoWonder FAQs

  • When was NoWonder founded?

    NoWonder was founded in 2017.

  • Where is NoWonder headquartered?

    NoWonder is headquartered in Sandy, UT.

  • What is the size of NoWonder?

    NoWonder has 15 total employees.

  • What industry is NoWonder in?

    NoWonder’s primary industry is Drug Delivery.

  • Is NoWonder a private or public company?

    NoWonder is a Private company.

  • What is the current valuation of NoWonder?

    The current valuation of NoWonder is .

  • What is NoWonder’s current revenue?

    The current revenue for NoWonder is .

  • How much funding has NoWonder raised over time?

    NoWonder has raised $32.7M.

  • Who are NoWonder’s investors?

    ABC International (Vancouver), Horizons Ventures, The Global Value Investment Portfolio Management, Happiness Capital, and Impact Assets are 5 of 10 investors who have invested in NoWonder.

  • Who are NoWonder’s competitors?

    Pfizer (Vienna), Melinta Therapeutics, Pfizer Pakistan, Lakewood-Amedex, and Scynexis are some of the 47 competitors of NoWonder.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process